文献速递角膜与眼表疾病青光眼眼底病与葡萄膜炎

加拿大Boston I型人工角膜长期视觉结局

Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
PubMed 文献 · Br J Ophthalmol · 2020-02-17

单术者回顾性队列纳入74例85眼Boston I型人工角膜植入者,平均随访7.2年。7年时61.8%眼维持视力改善,术前青光眼和Stevens-Johnson综合征是视力失败危险因素,91.8%眼8年保留装置。

要点

  • 7年时61.8%眼维持术后视力改善。
  • 术前青光眼和Stevens-Johnson综合征与视力失败相关。
  • 8年装置保留率91.8%,并发症以 retroprosthetic membrane 38.8% 最常见。

核心结论

  • 近三分之二患者在人工角膜植入7年后视力改善。
  • 术前已知青光眼和Stevens-Johnson综合征是视力失败的术前危险因素。

研究设计与样本

  • 纳入至少5年随访者,包括重复植入眼。

主要发现

  • 平均随访7.2±1.3年。
  • 平均视力(logMAR)术前2.1±0.7,末次随访1.9±1.2。
  • 术前视力优于20/200者占2.4%,末次随访占36.5%。
  • 7年时61.8%眼维持术后视力改善。

关键数值与推荐

  • 视力失败定义为持续低于术前视力。
  • 8年累积并发症率:retroprosthetic membrane 38.8%、低眼压25.9%、新发青光眼23.5%、视网膜脱离17.6%、装置挤出8.2%、眼内炎5.9%。
  • 8年装置保留率91.8%。

临床怎么用

  • 术前应评估青光眼和Stevens-Johnson综合征病史以识别视力失败高危眼。
  • 长期随访需关注retroprosthetic membrane、低眼压、新发青光眼等并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To evaluate long-term visual outcomes of Boston type I keratoprosthesis (KPro) surgery and identify risk factors for visual failure. METHODS: Single surgeon retrospective cohort study including 85 eyes of 74 patients who underwent KPro implantation to treat severe ocular surface disease, including limbal stem cell deficiency, postinfectious keratitis, aniridia and chemical burns. Procedures were performed at the Centre hospitalier de l'Université de Montréal from October 2008 to May 2012. All patients with at least 5 years of follow-up were included in the analysis, including eyes with repeated KPro. Main outcome measures were visual acuity (VA), visual failure, defined as a sustained worse than preoperative VA, postoperative complications, and device retention. RESULTS: Mean follow-up was 7.2±1.3 years (±SD). Mean VA was 2.1±0.7 (logarithm of minimal angle resolution) preoperatively and 1.9±1.2 at last follow-up. There were 2.4% of patients with VA better than 20/200 preoperatively and 36.5% at last follow-up. Maintenance of improved postoperative VA was seen in 61.8% of eyes at 7 years. Preoperative factors associated with visual failure were known history of glaucoma (HR=2.7 (1.2 to 5.9), p=0.02) and Stevens-Johnson syndrome (HR=7.3 (2.5 to 21.4) p<0.01). Cumulative 8-year complication rates were 38.8% retroprosthetic membrane formation, 25.9% hypotony, 23.5% new onset glaucoma, 17.6% retinal detachment, 8.2% device extrusion and 5.9% endophthalmitis. The majority (91.8%) of eyes retained the device 8 years after implantation. CONCLUSION: Almost two-thirds of patients had improved VA 7 years after KPro implantation. Preoperative risk factors for visual failure were known glaucoma and Stevens-Johnson syndrome.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Szigiato AA, Bostan C, Nayman T, et al. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada. Br J Ophthalmol. 2020. PMID: 32066560. doi:10.1136/bjophthalmol-2019-315345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。